These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32146802)

  • 1. Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors.
    Szumera-Cieækiewicz A; Kuczkiewicz-Siemion O; Seliga K; Grabowska-Kierył M; Tysarowski A; Wągrodzki M; Świtaj T; Prochorec-Sobieszek M; Rutkowski P
    Pol J Pathol; 2019; 70(4):317-322. PubMed ID: 32146802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
    Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
    Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFE3-Expressing Epithelioid Rich Perivascular Epithelioid Cell Neoplasm (PEComa) of the Bladder with Unusual Benign Course.
    Chen XF; Yeong J; Chang KTE; Lim AST; Kuick CH; Lim TH; Sudhanshi J; Selvarajan S; Gan VHL; Khor LY
    Ann Clin Lab Sci; 2018 Jan; 48(1):110-115. PubMed ID: 29531006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature.
    Saluja K; Thomas J; Zhang S; Sturgis EM; Jain KS; Prieto VG; El-Naggar AK; Bell D
    Hum Pathol; 2018 Jun; 76():149-155. PubMed ID: 29208563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
    Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
    Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Williamson SR; Bunde PJ; Montironi R; Lopez-Beltran A; Zhang S; Wang M; Maclennan GT; Cheng L
    Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.
    Tanaka M; Kato K; Gomi K; Matsumoto M; Kudo H; Shinkai M; Ohama Y; Kigasawa H; Tanaka Y
    Am J Surg Pathol; 2009 Sep; 33(9):1416-20. PubMed ID: 19606011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma.
    McGregor SM; Alikhan MB; John RA; Kotler H; Bridge JA; Mujacic I; Kadri S; Segal J; Krausz T
    Am J Surg Pathol; 2017 May; 41(5):717-722. PubMed ID: 28009605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the histomorphologic spectrum of TFE3-rearranged perivascular epithelioid cell tumors.
    Maloney N; Giannikou K; Lefferts J; Bridge JA; Linos K
    Hum Pathol; 2018 Dec; 82():125-130. PubMed ID: 29626599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant TFE3-rearranged perivascular epithelioid cell neoplasm (PEComa) presenting as a subcutaneous mass.
    Shon W; Kim J; Sukov W; Reith J
    Br J Dermatol; 2016 Mar; 174(3):617-20. PubMed ID: 26385848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFE3-Fusion Variant Analysis Defines Specific Clinicopathologic Associations Among Xp11 Translocation Cancers.
    Argani P; Zhong M; Reuter VE; Fallon JT; Epstein JI; Netto GJ; Antonescu CR
    Am J Surg Pathol; 2016 Jun; 40(6):723-37. PubMed ID: 26975036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements.
    Neumann NM; Haffner MC; Argani P; Kao CS; Epstein JI
    Am J Surg Pathol; 2021 Feb; 45(2):169-177. PubMed ID: 33002920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perivascular epithelioid cell tumor (PEComa) with TFE3 gene rearrangement: clinicopathological, immunohistochemical, and molecular features.
    Shen Q; Rao Q; Xia QY; Yu B; Shi QL; Zhang RS; Zhou XJ
    Virchows Arch; 2014 Nov; 465(5):607-13. PubMed ID: 25239799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TFE3-rearranged perivascular epithelioid cell tumors: a clinicopathological analysis of eight cases].
    Qin Y; Yang L; Zhang HJ; Wei J; Liu YX; Zhang WH; Wen Z; Wang Z; Fan LN
    Zhonghua Bing Li Xue Za Zhi; 2024 Aug; 53(8):822-829. PubMed ID: 39103264
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant perivascular epithelioid cell tumor (PEComa) of cervix with TFE3 gene rearrangement: a case report.
    Liu F; Zhang R; Wang ZY; Xia Q; Shen Q; Shi S; Tu P; Shi Q; Zhou X; Rao Q
    Int J Clin Exp Pathol; 2014; 7(9):6409-14. PubMed ID: 25337301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TFE3 -Rearranged PEComa/PEComa-like Neoplasms : Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy.
    Argani P; Gross JM; Baraban E; Rooper LM; Chen S; Lin MT; Gocke C; Agaimy A; Lotan T; Suurmeijer AJH; Antonescu CR
    Am J Surg Pathol; 2024 Jul; 48(7):777-789. PubMed ID: 38597260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFE3-rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape.
    Agaimy A; Acosta AM; Cheng L; Collins K; Fridman E; Schubart C; Williamson SR; Hartmann A; Trpkov K
    Histopathology; 2024 Nov; 85(5):783-793. PubMed ID: 39169706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinctive subset of PEComas harbors TFE3 gene fusions.
    Argani P; Aulmann S; Illei PB; Netto GJ; Ro J; Cho HY; Dogan S; Ladanyi M; Martignoni G; Goldblum JR; Weiss SW
    Am J Surg Pathol; 2010 Oct; 34(10):1395-406. PubMed ID: 20871214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanotic PEComa: A Rare But Distinctive Subtype Analyzed in a Series of 7 Cases.
    de la Fouchardiere A; Papke DJ; Pissaloux D; Russell-Goldman E; Tirode F; Fletcher CDM; Hanna J
    Am J Surg Pathol; 2024 Jan; 48(1):88-96. PubMed ID: 38117287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
    Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
    J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.